| | | Investing.com
SAN DIEGO, CA – Immunity Bio, Inc., a biotechnology firm specializing in biological products, announced today the resignation of John Owen Brennan from its Board of Directors, effective immediately. Brennan, who has served on the board since 2021, stepped down from his role and all related committee positions on February 7, 2025. According to the company's filing with the Securities and Exchange Commission, his departure is not due to any disagreements with the company's operations, policies, or practices.
I thought this was a likely move by IBRX. If he couldn't help with government contacts then he really had no role, plus his security clearance was revoked so he couldn't go into some government buildings. |
|
